Toward Targeted Oral Vaccine Delivery Systems: Selection of Lectin Mimetics from Combinatorial Libraries
The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Abstract
Purpose Various lectins bind specifically to oligosaccharides on intestinal cells. Exploiting this specificity, Ulex europaeus agglutinin I (UEA1) has been used as a ligand for targeted oral vaccine delivery to M cells (antigen-presenting cells) in follicle-associated epithelium. In this study we characterized compounds identified from mixture-based positional scanning synthetic combinatorial libraries, which mimic UEA1 and, thus, may have properties applicable to targeted drug delivery.Methods Two UEA1 mimetics were synthesized and their activity was verified on live cells. The ability of the lead compound, a tetragalloyl D-Lysine amide construct (4-copy gallic acid construct), to deliver dye-loaded polystyrene particles to M cells was assessed in an in situ mouse gut loop model.Results The 4-copy gallic acid construct inhibited UEA1 binding to Caco-2 cell membranes with an IC50 of 3 microM, a 650- to 5000-fold increase over the natural UEA1 substrate alpha-L-fucose. The biotin-labeled derivative of this construct demonstrated comparable binding activity as verified on live cells by fluorescence-activated cell sorting. Preclinical studies confirmed its ability to mediate M cell-specific delivery of streptavidin-coated particles in vivo.Conclusions Polyphenolic compounds, D-Lysine scaffolds with multiple galloyl groups, can mimic functional activities of UEA1. Properties of such molecules, including low molecular weight, stability, ease of synthesis and low cost, highlight their potential for application in targeted vaccine delivery.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A tetragalloyl d-lysine amide construct, as the main compound of two UEA1 mimetics, leads to successful delivery of coated PS particles to mouse M cells and might specifically bind via α-l-fucose [117].”
From Use of lectin-functionalized particles for oral immunotherapy (2012) · cites this paper as [117]
In the citing paper
“As data on the expression of specific receptors on human M cells is lacking, the development of M-cell-specific targeting strategies, such as the coating of particles with lectins or lectin mimetics [117,119], might be more difficult than expected.”
From Use of lectin-functionalized particles for oral immunotherapy (2012) · cites this paper as [117]
In the citing paper
“lectins are often toxic and susceptible to proteolytic degradation in the GI tract, which renders some of them inappropriate for in vivo application [105,117].”
From Use of lectin-functionalized particles for oral immunotherapy (2012) · cites this paper as [117]
Citations
Cites
Mammen, M., Choi, S.-K., & Whitesides, G. M. (1998) · Angewandte Chemie International Edition · doi:10.1002/(sici)1521-3773(19981102)37:20<2754::aid-anie2754>3.0.co;2-3 · Cited by 4,110 · cited 1×
“Protein–carbohydrate interactions are notable examples where enhanced affinity is achieved through polyvalent binding (18).”
BackgroundArtursson, P. (1990) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600790604 · Cited by 844 · cited 1×
“Caco-2 cell (ATCC, Rockville, ML, USA) membrane fractions were prepared from confluent cell monolayers grown in 75-cm(2) flasks for up to 1 week at 37°C and 5% CO2 as previously described (11,12).”
MethodPinilla, C., Appel, J. R., Blanc, P., & Houghten, R. A. (1992) · PubMed · Cited by 326
Self-citationMixture-Based Synthetic Combinatorial Libraries
Houghten, R. A., Pinilla, C., Appel, J. R., Blondelle, S. E., Dooley, C. T., Eichler, J., Nefzi, A., & Ostresh, J. M. (1999) · Journal of Medicinal Chemistry · doi:10.1021/jm990174v · Cited by 256
Self-citationPurification and characterization of an anti-H(O) phytohemagglutinin of Ulex europeus
Matsumoto, I., & Osawa, T. (1969) · Biochimica et Biophysica Acta (BBA) - Protein Structure · doi:10.1016/0005-2795(69)90193-7 · Cited by 231 · cited 1×
“The 2-copy construct exhibited an IC50 value of 96 M, and the 4-copy construct 3 M, when competed against biotin-labeled UEA1 in the single-tier competition assay, representing a significant enhancement over L-fucose, which has been shown to have a range of inhibitory activity between 2000 and 15,000 M (22,24,25).”
BackgroundDifferential expression of lectin-binding sites defines mouse intestinal M-cells.
Clark, M. A., Jepson, M. A., Simmons, N. L., Booth, T. A., & Hirst, B. H. (1993) · Journal of Histochemistry & Cytochemistry · doi:10.1177/41.11.7691933 · Cited by 221 · cited 2×
“It has been established that the surface expression of oligosaccharides differs between M cells and adjacent enterocytes and that UEA1 labels the surface of mouse Peyer’s patch M cells in a highly specific manner (4,21).”
BackgroundLectin-bearing Polymerized Liposomes as Potential Oral Vaccine Carriers
Chen, H., Torchilin, V., & Langer, R. (1996) · Pharmaceutical Research · doi:10.1023/a:1016030202104 · Cited by 186
Kinsella, B. T., O’Mahony, D. J., & FitzGerald, G. A. (1997) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)36684-4 · Cited by 172
Self-citationKinsella, B. T., O’Mahony, D. J., & FitzGerald, G. A. (1997) · PubMed · Cited by 160
Self-citationUlex europaeus 1 lectin targets microspheres to mouse Peyer's patch M-cells in vivo
Foster, N. M. (1998) · Vaccine · doi:10.1016/s0264-410x(97)00222-3 · Cited by 146 · cited 11×
“This is understandable in that early combinatorial strategies focused on peptides, primarily because of the existence of phage display libraries featuring extracellular presentation of millions of candidate ligands, and peptides were associated with biologic instability and poor membrane permeability in the GIT.”
BackgroundMethodInfluential
Research works printed but not linked: 2
- C. Pinilla, I. Lambkin, C. Hamashin, L. Osthues, L. Higgins, S. Russell, J. Dee, A. Schink, R. Houghten, and D. O'Mahony. Use of mixture-based combinatorial libraries to identify ligands that target receptors in the gastro-intestinal tract. Br. J. Pharmacol. 134:192P(2001).
- C. Grandjean, G. Angyalosi, E. Loing, A. Adriaenssens, O. Melnyk, V. Pancre, C. Auriault, and H. Gras-Masse. Novel hyperbranched glycomimetics recognized by the human mannose receptor: quinic or shikimic acid derivatives as mannose bioisosteres. Chem. Biochem. 2:747-757 (2001).
Cited by
Nanoparticles for oral delivery: Design, evaluation and state-of-the-art
Date, A. A., Hanes, J., & Ensign, L. M. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.06.016 · Cited by 539
“Studies have also been carried out to develop/identify lectin mimetics to overcome drawbacks associated with lectins [58].”
BackgroundKeynote review: intestinal Peyer's patch M cells and oral vaccine targeting
Brayden, D. J., Jepson, M. A., & Baird, A. W. (2005) · Drug Discovery Today · doi:10.1016/s1359-6446(05)03536-1 · Cited by 224
Xu, Y., Shrestha, N., Préat, V., & Beloqui, A. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.04.006 · Cited by 214
Delivery strategies to enhance oral vaccination against enteric infections
Davitt, C. J. H., & Lavelle, E. C. (2015) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.03.007 · Cited by 170
“Furthermore, a lowmolecular weight UEA-1 peptidomimetic has also been shown to enhance particle uptake after oral delivery [234].”
BackgroundGut-associated lymphoid tissues for the development of oral vaccines
Kunisawa, J., Kurashima, Y., & Kiyono, H. (2011) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2011.07.003 · Cited by 159
Targeted nanoparticles with novel non-peptidic ligands for oral delivery
Rieux, A. D., Pourcelle, V., Cani, P. D., Marchand‐Brynaert, J., & Préat, V. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.01.002 · Cited by 159
Mushroom lectins: Current status and future perspectives
Singh, R. S., Bhari, R., & Kaur, H. P. (2010) · Critical Reviews in Biotechnology · doi:10.3109/07388550903365048 · Cited by 154
“…et al. (2004) Xylaria hypoxylon Inhibits M1 and HepG2 cells n.d. n.d. Liu et al. (2006) n.d.: not determined So far, some of the plant lectins such as tomato lectin (Naisbett and Woodley, 1995) and Ulex europeus lectin (Lambkin et al., 2003) have been assessed for drug delivery applications.”
Kim, S., Seo, K.-W., Kim, J., Lee, K., & Jang, Y. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0903184 · Cited by 138
“In addition, oral administration of killed whole bacteria, together with UEA-1 as an M cell-targeting ligand, induced a protective immune response even without the use of an immunostimulatory adjuvant, although questions were raised about the safety and binding specificity of UEA-1 (51).”
BackgroundM cell targeting by lectins: a strategy for mucosal vaccination and drug delivery
Jepson, M. A., Clark, M. A., & Hirst, B. H. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2003.10.018 · Cited by 130
An Overview of Nanocarrier-Based Adjuvants for Vaccine Delivery
Petkar, K. C., Patil, S. M., Chavhan, S. S., Kaneko, K., Sawant, K. K., Kunda, N. K., & Saleem, I. Y. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13040455 · Cited by 109
“Various non-biodegradable materials such as gold [137], carbon [138], silica [139], quantum dots [140] and polystyrene [141] have been utilized as vaccine delivery systems and adjuvants.”
Crossing the barrier: Targeting epithelial receptors for enhanced oral vaccine delivery
Devriendt, B., Geest, B. G. D., Goddeeris, B. M., & Cox, E. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.02.006 · Cited by 106
“To overcome these problems, a high throughput screen of mixture-based synthetic combinatorial compound libraries in a UEA-1 competitive binding assay to human IEC has been developed, which identified stable non-toxic small lectin mimetics with a high specificity forα-L-fucose residues [49].”
BackgroundChitosan-based particulate systems for the delivery of mucosal vaccines against infectious diseases
Singh, B., Maharjan, S., Cho, K., Cui, L., Park, I., Choi, Y., & Cho, C. (2017) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2017.10.101 · Cited by 96
Exploiting receptor biology for oral vaccination with biodegradable particulates
Foster, N. M., & Hirst, B. H. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2004.09.009 · Cited by 64
Situ, W., Li, X., Liu, J., & Chen, L. (2015) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.5b00393 · Cited by 61
M cell-targeted delivery of vaccines and therapeutics
KuoLee, R., & Chen, W. (2008) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.5.6.693 · Cited by 63
Mucosal targeting of allergen-loaded microspheres by Aleuria aurantia lectin
Roth-Walter, F., Schöll, I., Untersmayr, E., Ellinger, A., Boltz-Nitulescu, G., Scheiner, O., Gabor, F., & Jensen-Jarolim, E. (2005) · Vaccine · doi:10.1016/j.vaccine.2004.11.052 · Cited by 55
In Vivo Phage Display to Identify M Cell-Targeting Ligands
Higgins, L. M., Lambkin, I., Donnelly, G., Byrne, D., Wilson, C., Dee, J., Smith, M. W., & O’Mahony, D. J. (2004) · Pharmaceutical Research · doi:10.1023/b:pham.0000022418.80506.9a · Cited by 56
“The modified particulate system was administered to mouse intestinal ileal loops, essentially as previously outlined (9).”
BackgroundMethodSelf-citationTargeted Delivery of Immunogen to Primate M Cells with Tetragalloyl Lysine Dendrimer
Misumi, S., Masuyama, M., Takamune, N., Nakayama, D., Mitsumata, R., Matsumoto, H., Urata, N., Takahashi, Y., Muneoka, A., Sukamoto, T., et al. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0802928 · Cited by 53
“(26, 34) reported that a synthetic multivalent polygalloyl derivative (SMPD) is a competitor of UEA-1 and appears to have high affinity for the fucose receptor on murine M cells.”
BackgroundTargeted Nasal Vaccination Provides Antibody-Independent Protection Against Staphylococcus aureus
Misstear, K., McNeela, E. A., Murphy, A. G., Geoghegan, J. A., O’Keeffe, K. M., Fox, J., Chan, K., Heuking, S., Collin, N., Foster, T. J., et al. (2013) · The Journal of Infectious Diseases · doi:10.1093/infdis/jit636 · Cited by 44
Apical membrane receptors on intestinal M cells: potential targets for vaccine delivery
Brayden, D. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2003.10.036 · Cited by 43
Needle-Free Immunization with Chitosan-Based Systems
Singh, B., Maharjan, S., Sindurakar, P., Cho, K., Choi, Y.-J., & Cho, C. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19113639 · Cited by 42
“Lectins are one of the natural ligands that have high affinity with sugar moieties on intestinal cells [123].”
BackgroundUse of lectin-functionalized particles for oral immunotherapy
Diesner, S. C., Wang, X.-Y., Jensen-Jarolim, E., Untersmayr, E., & Gabor, F. (2012) · Therapeutic Delivery · doi:10.4155/tde.11.146 · Cited by 40
Gamazo, C., Martín‐Arbella, N., Brotons-Canto, A., Camacho, A. I., & Irache, J. M. (2015) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2015.01.010 · Cited by 37
Recent Advances in Microparticle and Nanoparticle Delivery Vehicles for Mucosal Vaccination
McNeela, E. A., & Lavelle, E. C. (2011) · Current topics in microbiology and immunology · doi:10.1007/82_2011_140 · Cited by 37
“Lambkin et al. (2003) showed that polystyrene particles coated with one of these UEA-I mimetics adhered to murine M cells in vivo.”
BackgroundDrug delivery to the small intestine
Friend, D. R. (2004) · Current Gastroenterology Reports · doi:10.1007/s11894-004-0052-z · Cited by 34
Microencapsulation of Vaccine Antigens and Adjuvants for Mucosal Targeting
Rajapaksa, T. E., & Lo, D. D. (2010) · Current Immunology Reviews · doi:10.2174/157339510790231798 · Cited by 29
“These lectin mimetics have advantages over natural lectins including their smaller size (1500 Da), ease of production, stability during formulation procedures and GI targeting [ 47 ].”
BackgroundMethodLectins and glycoconjugates in drug delivery and targeting
Lehr, C., & Gabor, F. (2003) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2003.10.013 · Cited by 26
Microparticles for oral delivery of vaccines
Mutwiri, G., Bowersock, T. L., & Babiuk, L. A. (2005) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2.5.791 · Cited by 26
“Similarly, synthetic compounds that mimic UEA1 mediate M-cell-specific delivery of particles in vivo [73].”
BackgroundRussell-Jones, G. J. (2011) · Therapeutic Delivery · doi:10.4155/tde.11.129 · Cited by 24
Pohlmeyer, I., Jörns, J., Schumacher, U., Van Damme, E. J. M., Peumans, W. J., Pfüller, U., & Neumann, U. (2005) · Journal of Veterinary Medicine Series A · doi:10.1111/j.1439-0442.2005.00696.x · Cited by 20
Identification of novel small-Molecule Ulex europaeus I mimetics for targeted drug delivery
Hamashin, C., Spindler, L., Russell, S., Schink, A., Lambkin, I., O’Mahony, D. J., Houghten, R. A., & Pinilla, C. (2003) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2003.09.002 · Cited by 10
Self-citationBhatia, S., & Dahiya, R. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-802221-4.00008-x · Cited by 10
Kunisawa, J., McGhee, J. R., & Kiyono, H. (2007) · Springer eBooks · doi:10.1007/978-0-387-72232-0_14 · Cited by 11
Schreiner, J., Brettner, F. E. B., Gier, S., Vogel‐Kindgen, S., & Windbergs, M. (2024) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2024.114408 · Cited by 8
Mucosal Vaccine Delivery and M Cell Targeting
Gupta, P. N. (2014) · Advances in delivery science and technology · doi:10.1007/978-3-319-11355-5_9 · Cited by 7
“There have been successful efforts made into in vivo targeting to mouse M cells by conjugating the lectin to polymerized liposomes [ 30 ] and also to latex particles [ 31 ].”
MethodCommercialization of Nanovaccines: Utopia or a Reality?
Aqib, A. I., Zaheer, T., Usman, M. H., Arslan, M., & Atta, K. (2022) · Wiley eBooks · doi:10.1002/9781119858041.ch17 · Cited by 1
Molecular design of advanced oral protein delivery systems using complexation hydrogels
Wood, K. M. (2006) · Texas ScholarWorks (Texas Digital Library) · Cited by 4
Oral Delivery of Macromolecules for the Development of Therapeutic Agents
Lee, H. J., & Choi, C. (2011) · Wiley eBooks · doi:10.1002/9780470571224.pse439
Lectin-coated particulate delivery systems for oral administration
Reis, C. P., Ramalhete, N., & Fitas, M. (2016) · doi:10.4155/fseb2013.13.109
Metadata
- Authors
- Lambkin, I., Pinilla, C., Hamashin, C., Spindler, L., Russell, S., Schink, A., Moya-Castro, R., Allicotti, G., Higgins, L., Smith, M., Dee, J., Wilson, C., Houghten, R., & O'Mahony, D.
- Affiliations
- Trinity College Dublin (IE)
- General Atomics (United States) (US)
- Torrey Pines Institute For Molecular Studies (US)
- Corresponding author
- Lambkin, Imelda
- Venue
- Pharmaceutical Research
- Published
- 2003-08
- Volume
- 20
- Issue
- 8
- Pages
- 1258-1266
- ISSN
- 0724-8741 (ISSN-L)
- 1573-904X
- OpenAlex
- W1574479676
- Cited by
- 39
- References
- 26
- Citations by year
- 2024: 1 · 2022: 1 · 2021: 1 · 2020: 1 · 2018: 1 · 2017: 1 · 2016: 2 · 2015: 4 · 2014: 1 · 2013: 2 · 2012: 2
- FWCI
- 2.82
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springernature.com/gp/researchers/text-and-data-mining (tdm)
- www.springernature.com/gp/researchers/text-and-data-mining (vor)
- Locations
- Pharmaceutical Research (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Elan
- Topics
- Physical Sciences › Chemistry › Organic Chemistry › Carbohydrate Chemistry and Synthesis
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Glycosylation and Glycoproteins Research
- Keywords
- oral vaccine delivery, Ulex europaeus agglutinin I, M cells, follicle-associated epithelium, polyphenols, targeted drug delivery, Caco-2 cells, oligosaccharide binding
- MeSH terms
- Administration, Oral, Animals, Cell Membrane, Drug Carriers, Gallic Acid, Humans, Mice, Inbred BALB C, Microscopy, Fluorescence, Polystyrenes, Protein Binding, Structure-Activity Relationship, Vaccines, Molecular Mimicry, Caco-2 Cells, Peptide Library, Streptavidin, Combinatorial Chemistry Techniques, Plant Lectins, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.